Kyverna Therapeutics appoints Naji Gehchan as CMO to advance KYV-101, its CD19-directed CAR-T therapy for autoimmune diseases ...

Spektus Pharma, a Quebec-based specialty pharma company developing therapeutics for the treatment of CNS disorders, has ...

The FDA issues a warning letter to Sanofi over manufacturing violations at its Massachusetts site, citing contamination and ...

UK pharma major AstraZeneca today revealed that, this week, it has received two positive recommendations from the National ...

Sanofi secures EU approval for Sarclisa with VRd for newly diagnosed multiple myeloma patients ineligible for stem cell ...

Rett syndrome is a rare neurological and developmental disorder that leads to a gradual decline in motor skills and language.

London, UK-based LinkGevity today announced it has been selected for the prestigious KQ Labs Program, delivered by the Francis Crick Institute, Europe’s largest biomedical research center.

Specifically, Catalent's commercial cell therapy manufacturing facility in Princeton, New Jersey, will support manufacturing ...

This article explores the latest conversations around generic topical and transdermal drug delivery systems (TDS) in the US ...

Patent-filing research conducted by law firm Withers & Rogers suggests that CAR T-cell therapy capability has reached a pivotal point on route to market, and first-line use of these promising ...

Arvinas announces leadership changes as John Northcott steps down as CCO, with Alex Santini filling the role on an interim ...

US healthcare giant Johnson & Johnson announced the US Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Spravato (esketamine) CIII nasal spray as the first ...